Rentschler Biopharma announced today that Dr. Thomas Rösch will join the Company as vice president Biopharma Engineering & Technology, effective April 1, 2018.
He will be responsible for advanced biopharmaceutical engineering projects to enhance site and capacity, in line with the Company's strategy. Dr. Rösch has more than 16 years of industry experience, including senior leadership positions in engineering, maintenance and project management within pharma, biopharma and research & development.
"Dr. Thomas Rösch has excellent biopharmaceutical process and construction expertise and will drive our major technology and capacity expansion projects," said Dr. Ralf Otto, chief operating officer of Rentschler Biopharma. "With his exceptional knowledge and experience of pharma and biopharma infrastructure projects we are, now, perfectly positioned to maximize our efforts in the further development and optimization of our manufacturing facilities. Dr. Rösch's understanding of improving existing and building up new sites globally will accelerate our expansion in line with our clients' needs."
Dr. Thomas Rösch said, "The CDMO sector is entering a very exciting phase driven by new technologies and modalities. Together with the Rentschler Biopharma team, we will further evolve our footprint by optimizing process engineering and technology applications. It will be thrilling to contribute to the successful implementation of Rentschler Biopharma's strategy."
Prior to joining Rentschler Biopharma, Dr. Rösch held the position of head of Global Engineering & Technology Pharma & Chemicals at Boehringer Ingelheim Pharma GmbH & Co KG., Ingelheim, Germany.